Hypovolemia, as well as hyperosmolality, is a potent stimulus for accelerating arginine vasopressin (AVP) secretion [1] . In contrast to the situation that the cerebral neurons engaged in the hyperosmotic excitation of AVP cells in the hypothalamic supraoptic nucleus (SON) and paraventricular nucleus (PVN) (AV3V) is a pivotal area for osmotic responses and integration of autonomic functions. The purpose of this study was to investigate whether the gamma-aminobutyric acid (GABA)-ergic activity in the AV3V may be involved in the regulation of arginine vasopressin (AVP) secretion and related phenomena under the conditions with or without hypovolemia. Experiments were performed in conscious rats. We found that AV3V infusion with the GABA A receptor antagonist bicuculline in euvolemic rats caused prompt increases in plasma AVP, osmolality, glucose, arterial pressure and heart rate. The effects of the bicuculline infusion were abolished by prior infusion of a GABA A receptor agonist, muscimol. When repeated twice with a 10-min interval, removal of systemic blood (10 mL/ kg body weight) lowered arterial pressure and enhanced plasma AVP, osmolality, glucose and angiotensin II. Muscimol infusion in the AV3V, but not in the cerebral ventricle, inhibited the responses of plasma AVP and glucose, despite having no effect in a sham hemorrhagic state. The inhibition of the AVP response by the muscimol infusion was also verified in rats given a combined stimulus of bleeding plus an osmotic load. In contrast, AV3V infusion with the GABA B receptor agonist baclofen tended to intensify the hemorrhagic responses of plasma AVP and glucose, despite its potency to prevent the hemorrhagic fall in arterial pressure. These results, taken together with our previous data, suggest that hypovolemic stimuli, like hyperosmotic stimuli, may promote AVP secretion by causing the inhibition of AV3V GABA A -ergic activity responsible for potentiation of glutamatergic activity.
information is conveyed from the peripheral organs to the nucleus of the solitary tract (NTS) and the ventrolateral medulla (VLM) via the carotid sinus or aortic depressor nerve, and then transferred to the SON and PVN through pathways that directly connect these brainstem loci with the hypothalamic nuclei [2] [3] [4] [5] . However, there are various observations suggesting that the neurons of the anteroventral third ventricular region (AV3V) responsible for osmotic AVP release may participate in hypovolemic and hypotensive activation of AVP cells. For example, the median preoptic nucleus (MnPO), a major AV3V structure that includes synapses of osmotic circuits [4, 6, 7] , and the subfornical organ (SFO), a neighboring area with osmosensitivity [8] , receive afferents from the NTS and VLM (A1 region) [9] [10] [11] [12] , and electrical stimulation of the A1 region activates MnPO neurons projecting to the roles of GABA A and GABA B receptors in the AV3V in controlling AVP secretion and related autonomic function under euvolemia and the hypovolemia with or without hypotension. First, we examined the effects of AV3V infusion with the GABA A antagonist bicuculline [30] on plasma AVP and related variables in the absence or presence of prior infusion with the GABA A agonist muscimol. Next, the influences of AV3V application of muscimol or the GABA B agonist baclofen [30] were examined on those variables under circumstances with or without normotensive bleeding, hypotensive bleeding or a combined stimulus of the bleeding plus an osmotic load. Since drugs applied to the AV3V may produce effects through diffusion into the cerebral ventricle or adjacent areas, responses to the administration of these drugs into the ventricle or extra-AV3V regions were also examined for comparison.
materials and methods

Animals and surgery
All procedures were performed according to the National Institute of Health Guide for the Care and Use of Laboratory Animals (Washington DC, USA), under the strict control of the Ethics Committee of Animal Care and Experimentation, Niigata University, Japan.
Male Wistar rats (270-360g) were anesthetized with pentobarbital sodium (50 mg/kg i.p.) and placed in a stereotaxic apparatus (Narishige, Tokyo, Japan). Following a scalp incision, the lambda and bregma were located and the skull was leveled. A hole was drilled in the skull, and a stainless-steel guide cannula with an outer diameter of 0.5 mm equipped with a stylet was lowered to just above the MnPO, a primary structure of the AV3V [4] . The coordinates of the tips were 0.3 mm posterior to the bregma, on the midline, and 6.6 mm below the surface of the skull [31] . In some rats, the tips were deviated slightly from the above point or were lowered into the lateral cerebral ventricle, in order to compare the potency of the drug when applied to extra-AV3V regions. The coordinates of the ventricular tips were 0.8 mm posterior to the bregma, 1.5 mm right of the midline and 3.7 mm below the surface of the skull. The implanted cannulae were fixed to the skull with small screws and dental resin. After the surgery, the rats were injected i.m. with penicillin G (30,000 U). The rats were kept in individual cages and given food and water ad libitum.
At 7-9 days after surgery, the rats were catheterized PVN [11] . Moreover, hypovolemic stimuli affected the release of neurotransmitters in the AV3V [10, 11] , and the stimulus-evoked response in AVP secretion, as in water intake or blood pressure [13] , is prevented by AV3V application of neurotropic drugs [14] [15] [16] .
The issue of how AV3V may contribute to the regulation of AVP secretion under hypovolemia has scarcely been investigated to date. However, regarding the mechanism implicated in osmotic hormone release, stimulus-evoked inhibition of gamma-aminobutyric acid (GABA)-ergic activity that causes excitation of local glutamatergic neurons has been proposed to play an essential role in activating AVP cells [17] . Accordingly, if AV3V plays certain roles in processing or integrating both the hypertonic and hypovolemic signals to regulate the excitability of AVP cells [1, 18] , it is likely that the two kinds of amino acid neurons also function to control AVP secretion under hypovolemia. Consistent with this notion, blockade of glutamatergic receptors in the AV3V elicits inhibition of hemorrhagic AVP release [15, 16] , as well as hyperosmotic hormone secretion [16, 19] . Regarding GABAergic innervation in the AV3V, it has been reported that GABAergic fibers, like glutamatergic fibers, extend from the SFO or organum vasculosum of the lamina terminalis (OVLT), an AV3V osmoreceptor site, to MnPO neurons to regulate their excitability via ionotropic GABA A and metabotropic GABA B receptors [20, 21] . Moreover, acute fluid depletion reduces GABA synthesis in the AV3V or SFO [22] . It is therefore conceivable that GABA receptors in the AV3V may be involved in the AVP-releasing mechanism triggered by hypovolemia. In accord with this hypothesis, the plasma AVP response to a hypovolemic or hypotensive stimulus was inhibited by a manipulation that potentiated GABA action in the circumventricular region [23, 24] . Nevertheless, the validity of our proposal requires further evaluation, because the specific regions in which a GABAergic mechanism may have contributed to the AVP secretion have not been located. As such, areas other than the AV3V remain possible candidates, including the PVN [25] and circumventricular sites in the brainstem [26] . In addition, studies involving a tissue destruction technique were unable to show involvement of the AV3V in hypovolemic AVP secretion [27, 28] . Furthermore, it is still uncertain whether GABA B receptor activity in the AV3V [20, 21, 29] can influence AVP secretion in the presence of a hypovolemic stimulus.
The purpose of the present study was to clarify the bleeding in Groups (2) -(7) were 15 min. The i.v. infusion with 0.15 or 2.5 mol/L NaCl in Groups (4) and (5) was started at 1 min before the first bleeding mentioned below (at -1 min in Fig. 1 ) and continued to the end of experiments. Potency of the i.v. infusion with 2.5 M NaCl to stimulate AVP secretion has repeatedly been demonstrated in previous studies [16, 17, 19] . Bicuculline and muscimol were dissolved in distilled water and then diluted with isotonic saline. Baclofen was dissolved in a neutralized saline solution. The dose of bicuculline, muscimol and baclofen were determined on the basis of previous studies [17, 25, 26, 32] .
In the treatment Group (1), blood samples were collected at 5 min before and 5 and 15 min after the second intracranial infusion with bicuculline or vehicle. Namely, 3-mL blood samples were taken from the femoral arterial line over a period of about 30 s while supplying the same volume of warm (37 °C) donor blood via the jugular venous line. In the treatment Groups (2) -(7), the first blood samples (C) were obtained at 10 min after the intracranial infusion with muscimol, baclofen or vehicle (Fig. 1) . After 5 min, 10 mL/kg body weight (BW) of femoral arterial blood, equal to about 14% of the total blood volume [33] , was taken over a period of 30 s and discarded. An equal volume of the donor blood was supplied through the jugular line for the groups (2), (4) and (6) that received sham bleeding, but not for the groups (3), (5) and (7) in order to use the blood removal as a stimulus to cause normotensive hypovolemia (Fig. 1) . Two further blood samplings of the same volume were conducted at 10-min intervals with (for sham bleeding) or without (for bleeding to cause hypotensive hypovolemia) supplying the donor blood (Fig. 1) . The collected blood was retained as the second and third samples (B1 and B2).
Intracranial infusion was performed at a rate of 1 µL/ min for 1 min, using 30-gauge stainless-steel tubing that protruded 1.0 mm (for AV3V infusion) or 0.5 mm (for ICV infusion) beyond the ends of the guide cannulae. The upper end of the infusion tubing was connected to a microsyringe set in a Harvard pump (model 11; South Natick, MA, USA) via polyethylene tubing. More than 2 min were allowed to elapse before withdrawing the infusion tubing, in order to permit drug movement away from the tip. The i.v. infusions of 0.15 or 2.5 mol/L NaCl in Groups (4) and (5) were carried out at a rate of 0.15 mL/kg BW/min for 21 min. The donor blood was prepared on the day of the experiments. The trunk with PE-50 tubing in the right jugular vein and left femoral artery under anesthesia with pentobarbital sodium. When hypertonic or isotonic saline was to be administered, the left femoral vein was also catheterized with the tubing. These tubes were filled with heparinized saline (240 U/mL), sealed, exteriorized and secured at the back of the neck.
Experiments
Experiments were conducted at 1 or 2 days after the vascular catheterization. The rats were transferred into individual plastic boxes (8 x 8 x 25 cm) that permitted freedom of movement. After about 60 min, the arterial line was connected to a pressure transducer (Omeda, Tokyo, Japan) connected to an AP-600G amplifier (Nihon Kohden, Tokyo, Japan). The output signals from the amplifier were sent to a personal computer system through a PowerLab/4s (AD Instruments Japan, Tokyo, Japan) and processed for recordings and analyses of arterial pressure and heart rate. A period of 30-60 min was necessary for these cardiovascular parameters to stabilize. The rats then underwent one of the following treatments: The time intervals between the first and the second intracranial infusions in Group (1) and those between the intracranial infusion and the first bleeding or sham 
nmol).
These AV3V infusions were carried out over a 1-min period represented by an X just above the time scale. After 10 min, the first blood samples (C) were taken from the femoral artery while returning an equal volume of the donor blood via the jugular vein.
Recordings of AP and HR, therefore, were stopped transiently during the sampling periods. After 5 min, 10 mL/kg body weight of femoral arterial blood was collected over a period of 30 s with (for sham bleeding, S1) or without (for bleeding, T1) returning the donor blood, and discarded. Two further blood samples (B1 and B2) were then obtained at 10-min intervals with (S2 and S3) or without (T2 and T3) returning equal volumes of the donor blood. The characters C, B1 and B2 correspond to those in Figs. 2 and 6 or ]ANG II were 95.5 ± 7.4 % (n=22) at doses of 48.1-240.4 pmol/L. The values given for plasma AVP and ANG II were corrected for losses during the extraction with mean recoveries of 55.8 and 95.5%, respectively. The within-and between-assay coefficients of variation for the AVP assay were, 10.1% and 13.9%, respectively, while those for the ANG II assay were 6.7 and 9.3%, respectively. The minimal detection limit of the assay was 0.46 pmol/L plasma for AVP and 7.7 pmol/L plasma for ANG II.
Plasma osmolality was estimated by freezingpoint depression in an OM-6040 osmometer (Dai-ichi Kagaku, Kyoto, Japan), while glucose was estimated by an enzymatic method using hexokinase and glucose-6-phosphate dehydrogenase (SRL, Tokyo, Japan). Plasma sodium, potassium and chloride were determined using an EA-06 electrolyte analyzer (ATWill, Yokohama Japan). Systolic arterial pressure and heart rate were measured every 30 sec, and averaged over a 5-min (treatment group (1)) or 9-min period (treatment groups (2)- (7)) preceding blood sampling.
Statistics
All data are presented as means ± SEM. Withingroup comparisons were performed by one-way analysis of variance (ANOVA) with repeated measures (5% level of significance). Between-group comparisons were made by two-way ANOVA (5% level of significance). Subsequent to these analyses, comparisons of the means using Scheffe's F-test and Duncan's multiple-range test were performed to detect statistically significant within-group and between-group differences, respectively.
Results
Effects of bicuculline in the absence or presence of pretreatment with muscimol
AV3V infusions with bicuculline preceded by vehicle infusion promptly induced hyperactivity, and augmented plasma AVP, osmolality, glucose, arterial pressure and heart rate ( Table 1) . Plasma sodium, chloride and potassium were not significantly altered.
blood issuing after decapitation of normal rats that were lightly anesthetized with diethyl ether was collected into a heparinized beaker (150 U/rat).
Each blood sample was divided into two immediately after collection. A 2-mL aliquot was mixed with 0.1 mL of a solution containing 0.125 mol/L disodium ethylenediaminetetraacetic acid and 0.025 mol/L o-phenanthroline for subsequent measurements of plasma AVP and angiotensin II (ANG II). The remaining blood was used to measure plasma osmolality, glucose and electrolytes. Separation of plasma was performed by centrifugation at 3,000 x g at 2°C for 15 min. The plasma samples were stored at -35°C until use.
Histological analyses
After each experimental protocol had been completed, the rats were killed by i.v. injection of pentobarbital sodium. Trypan blue solution (2%) was infused intracranially, employing the same infusion tubing used for the experiments. The brain was then removed. The validity of the ICV infusion was verified by manually cutting the brain and inspecting the spread of the dye in the ventricular system. When infusion sites in the AV3V were to be inspected, the brains were fixed in 10% formalin for at least two weeks, and then immersed in 30% sucrose for more than 1 day. Afterwards, a freezing microtome was used to cut serial coronal sections of 50 µm in thickness from the piece of the brain that included a dye infusion site. The sections were mounted on glass slides and stained with 0.1% cresyl violet. The infusion sites were judged by the tissue injury made by the tubing, utilizing the brain atlas [31] as a reference.
Measurements
Plasma AVP and ANG II were extracted with acetone and petroleum ether, and determined by a radioimmunoassay. The assay procedures were described in detail elsewhere [34, 35] original records for arterial pressure and heart rate throughout six different experiments (Exps 1-6) are shown in Fig. 1 . In the two groups receiving AV3V infusion with vehicle or muscimol at -15 min, the basal levels of arterial pressure, heart rate and plasma variables including AVP, ANG II, osmolality, glucose or electrolytes were all similar at -5 min ( Fig. 2, C ; Table 2 , C). When a blood volume of 1% of the BW was withdrawn from the femoral artery at 0 min in the vehicle-infused rats (Fig. 1, T1 in Exp 4), significant increases were observed in heart rate and plasma AVP, ANG II, osmolality or glucose at 10 min ( Fig. 2,  B1 ; Table 2 , B1). However, arterial pressure did not change significantly ( Figs. 1 and 2 ), suggesting that the bleeding activated the peripheral volume receptors selectively, without stimulating the baroreceptors. Plasma sodium and chloride remained unchanged, whereas a slight but significant decrease was observed in plasma potassium. When the reduction in blood volHistological inspection indicated that the infusion sites of bicuculline in these rats were located in the MnPO, periventricular hypothalamic nucleus and their vicinity. In cases where the infusion sites were located in the anterior commissure, medial septal nucleus, nucleus of the vertical limb of the diagonal band and the lateral cerebral ventricle, no significant changes were observed in plasma AVP or any of the other parameters. When the AV3V infusions with bicuculline were preceded by infusions of muscimol, all of the bicuculline-evoked responses were abolished (Table 1) . When infusion with muscimol was followed by that of the vehicle, plasma glucose was the only variable that was significantly altered (Table 1) .
Effects of muscimol infusion in the AV3V or the cerebral ventricle under the bleeding condition with or without the osmotic load The experimental procedures and examples of the with the basal level. The second bleeding after 10 min provoked notable augmentations in plasma AVP. This steep increase in plasma AVP after the second bleeding, the observation that is consistent with the result of other laboratories, seems to have been caused by a characteristic of peripheral volume receptors that may stimulate AVP release in an exponential manner when graded reduction in blood volume occurs [1] . Plasma ANG II, osmolality and glucose were also enhanced remarkably (Table 2 , B2), whereas changes in plasma electrolytes were negligible. Such responses of cardiovascular parameters and osmolality to the second bleeding were similar in the muscimol-infused group (Fig. 1, Exp 5) . However, the responses of plasma AVP and glucose in this group were strikingly smaller and those of plasma ANG II were larger compared with the respective responses in the vehicle-infused group ( Fig. 2, B2 ; Table 2 , B2). It was verified that the infusion sites of muscimol were located in areas including the MnPO, periventricular hypothalamic nucleus, medial preoptic area and anteroventral periventricular nucleus (Fig. 3) . When muscimol was administered into the cerebral ventricle but not into the AV3V, arterial pressure was the only variable that showed a significant difference between the muscimol and vehicle groups (Fig. 4) . In Fig. 5 are represented the effects of AV3V infusion with muscimol on plasma AVP and other variables in rats undertaking the combined stimulus of bleeding plus the i.v. load with hypertonic NaCl. Application of the combined stimulus caused significant increases in plasma AVP, osmolality, sodium and chloride in rats given AV3V infusion with vehicle. Arterial pressure did not significantly change even after the second bleeding (Fig. 5, B2 ), probably due to activation of the sympathetic nervous system in response to the osmotic load [36] . This suggests that AVP release triggered by the cerebral osmoreceptor and peripheral volume receptors, but not that affected by the baroreceptors, may have contributed to the rise of plasma AVP. Plasma ANG II level was not affected by the combined stimulus, probably because it did not produce a reduction in arterial pressure (a primary factor that accelerates the renin release) and increased plasma sodium (a potent factor capable of decreasing renin release through macula densa function). The sodium concentrations in the C, B1 and B2 samples were, respectively, 140.4±1.0, 149.6±0.9 (P<0.05 vs. C) and 155.8±1.6 mmol/L (P<0.05 vs. B1). It was verified that AV3V infusion with muscimol remarkably ume caused by the sampling at 10 min was not compensated by donor blood and consequently became a second bleeding stimulus, arterial pressure promptly decreased (Fig. 1, T2 in Exp 4). Thereafter, it recovered toward the previous levels gradually and partially over time (Fig. 2, B2 ). Heart rate increased compared diminished the AVP response to the combined stimulus (Fig. 5) . The muscimol infusion did not change the responses of plasma osmolality, sodium or chloride and notably intensified the response of plasma ANG II. The ANG II event may have been related to an alteration in arterial pressure that tended to be reduced by the treatment (Fig. 5) . Hyperglycemic response to the combined stimulus was observed in the vehicle group, but not in the muscimol group, although a statistical significance was not noticed between the two groups. The glucose levels in the C, B1 and B2 samples were 6.8±0.3, 7.9±0.4 and 9.0±0.5 mmol/L (P<0.05 vs. C), respectively, in the vehicle group (n=5), and 7.6±0.3, 7.5±0.4 and 8.1±0.4 mmol/L, respectively, in the muscimol group (n=6). In rats undergoing sham bleeding or sham treatment of the combined stimulus (sham bleeding plus the i.v. load with isotonic NaCl), AV3V infusion with muscimol, as well as with vehicle, did not cause significant changes in plasma AVP, ANG II and glucose (Figs. 2 and 5, Table 2 ). When the vehicle, instead of muscimol, was administered into the AV3V prior to the sham bleeding or the sham treatment of the combined stimulus, none of the variables were significantly affected.
Effects of AV3V infusion with baclofen with or without a bleeding stimulus
In rats undergoing sham bleeding, AV3V infusion with baclofen provoked gradual elevations in arterial pressure and heart rate, without affecting plasma AVP, ANG II, osmolality, glucose, sodium, chloride and potassium (Fig. 1, Exp 3; Fig. 6 ). The potency of baclofen application for enhancing arterial pressure and heart rate was apparent even in bled rats (Fig. 1,  Exp 6; Fig. 6 ). Although the second bleeding caused a significant decrease in arterial pressure (Fig. 1, T2 in Exp 6), its resultant levels were higher in the baclofen group than in the vehicle group (Fig. 6, B2 ). Heart rate after the bleeding at T1 or T2 was also larger in the baclofen group (Fig. 6) . Similarly, the bleedingevoked increases in plasma AVP and glucose tended such effects by acting on the PVN or SON, because of the rare diffusion of an applied solution to these nuclei and the different responses induced by injecting drugs into these three loci. All of the effects of bicuculline were abolished by prior infusion of muscimol, a comto be larger in the baclofen group than in the vehicle group (Fig. 6) . The glucose levels in the C, B1 and B2 samples were 7.4±0.5, 7.7±0.4 and 9.8±0.6 mmol/L (P<0.05 vs. C or B1), respectively, in the vehicle group (n=5), and 7.3±0.2, 9.2±0.5 and 11.5±0.8 mmol/L (P<0.05 vs. C, B1 or vehicle group), respectively, in the baclofen group (n=5). Although it was confirmed that the bleeding provoked increases in plasma ANG II, osmolality and chloride and a decrease in plasma potassium, significant differences in these variables did not exist between the two bleeding groups with or without baclofen infusion (Fig. 6 ). Infusion sites of baclofen in these rats were verified to include the MnPO and the hypothalamic periventricular nucleus (Fig. 3) . When baclofen was infused into the vertical limb of the diagonal band, no effects on arterial pressure, heart rate and AVP were observed.
Discussion
The AV3V possesses GABA A and GABA B receptors [20, 21, 29] , as well as the NMDA and non-NMDA receptors for l-glutamate (Glu), the major excitatory neurotransmitter in the brain [16, 19, 37] . The GABA A receptor is a ligand-gated Cl -ion channel that mediates rapid synaptic transmission, while the GABA B receptor is bound to G proteins and modulates synaptic transmission through intracellular effector systems, leading to the activation of K + channels and inactivation of adenylate cyclase or Ca 2+ channels [30] . GABA is synthesized from Glu by glutamic acid decarboxylase (GAD), and a functional correlation exists between the GABAergic and glutamatergic systems in controlling various cerebral processes [25, 38] . We proposed previously that a glutamatergic system in the AV3V may act to mediate hypovolemic AVP secretion [15, 16] . However, whether the AV3V GABAergic system participates in the regulation of AVP secretion or related phenomena in the absence or presence of the hypovolemic stimulus remains to be clarified.
This study revealed that AV3V infusion with the GABA A antagonist bicuculline [30] promptly evokes notable increases in plasma AVP, osmolality, glucose, arterial pressure and heart rate. When the infusion site deviated from the AV3V to areas including the anterior commissure, medial septum, nucleus of the vertical limb of the diagonal band and lateral ventricle, hardly any of the variables were significantly affected. It is unlikely that AV3V infusion of bicuculline provoked hemorrhagic AVP response was not evoked secondarily via the effects on these AVP-controlling factors. Therefore, the finding that muscimol treatment inhibited the hemorrhagic AVP response, despite a lack of effect on the basal AVP level, may mean that the bleeding produced a situation wherein binding of exogenously applied muscimol to AV3V GABA A receptors became augmented. Considering that fluid depletion caused by a diuretic decreased the expression of GAD mRNA in the AV3V [22] , and that hypothalamic GABA was lessened by hypotension [46] , it seems likely that the hemorrhage may have decreased endogenous release of GABA and its binding to the GABA A receptor by inactivating GABAergic neurons in the AV3V or its vicinity, thereby permitting enhanced binding of the administered muscimol to occur. It has been shown that hemorrhage-evoked cardiovascular information sent to the NTS from the periphery reaches PVN or SON AVP neurons by passing through synapses at the VLM [2] [3] [4] . Since the excitability of VLM (A1) neurons projecting directly to the hypothalamic nuclei may be changed by signals from baroreceptors [2, 5] , a definite role of the A1 neurons in hemorrhagic AVP release cannot be excluded (Fig. 7, Top) , as was actually reported in catecholamine-depleted rats [47] . However, if there are nerve pathways that transmit cardiovascular information from the NTS, VLM or other brainstem loci to the AV3V (Fig. 7, Top) , it could also be possible that the AV3V mechanism for controlling AVP secretion may be modulated under hypovolemia. Consistent with this view, MnPO neurons, as well as SFO or OVLT neurons that extend both GABAergic and glutamatergic axons to MnPO neurons [20] , are innervated by projections from the NTS, VLM or LC (Fig. 7 , Top) [4, 9, 11, 12] . In addition, a hypovolemic stimulus can sensitize the osmoregulation mechanism of AVP release mediated by AV3V neurons [1, 18] , and AV3V application of muscimol was potent to diminish the AVP response caused by the combined stimulus of hypovolemia and hyperosmolality (Fig. 5) . Accordingly, our results may suggest that hypovolemia promotes AVP release and provoke hyperglycemia, at least in part, by inactivating AV3V GABA A -ergic neurons (asterisked neurons in Fig. 7 , Bottom), which may induce the activation of nearby glutamatergic neurons innervated by these neurons. This proposal is strongly supported by the observations that both the increase in plasma AVP caused by blockade of AV3V GABA A receptors and that caused by bleeding are prevented by inactivating glutapetitive GABA A agonist [30] . Taken together, it seems that dysfunction of GABA A receptors in the AV3V and its vicinity may stimulate AVP secretion and intensify the autonomic outputs involved in hyperosmolality, hyperglycemia, tachycardia and pressor action. Since AV3V administration of the GABA B antagonist phaclofen exhibits negligible effects on those variables [17] , these findings imply that, in the basal state, AV3V GABA A receptors are tonically and selectively activated by endogenous GABA to yield low basal levels of the variables. The increase in plasma osmolality after AV3V administration of bicuculline was partly caused by the rise in glucose, an event that is incapable of promoting AVP secretion in the absence of insulin depletion [39] . This suggests a negligible role of the evoked hyperosmolality in stimulating AVP release. It is plausible that blockade of AV3V GABA A receptors causes excitation of forebrain neurons responsible for activating hypothalamic AVP cells [6, 40] . Regarding the mechanism underlying the hyperglycemic, tachycardiac and pressor actions of bicuculline, it may be that blockade of AV3V GABA A receptors elicits sympathetic excitation and CRH release by activating neurons in the PVN, locus coeruleus (LC), VLM and the NTS through efferent pathways [4, 6, 7, [41] [42] [43] [44] [45] .
When applied to the AV3V in the absence of a bleeding stimulus, the GABA A agonist muscimol did not affect plasma AVP, glucose, heart rate or arterial pressure. In view of the potent AV3V action of its antagonist bicuculline on these parameters, the lack of effect of muscimol may indicate that the binding sites of GABA A receptors subserving the regulation of their levels had already been saturated with endogenous GABA, thereby making it difficult for the exogenous ligand to bind to these site to exert its action.
In contrast to such result, when administered into the AV3V instead of the cerebral ventricle, muscimol was highly effective in reducing the AVP response to bleeding. The hyperglycemic response, which was probably caused by the hemorrhagic excitation of sympathetic efferents [42] , was also lessened by muscimol administration. The findings for the AVP response are largely in accord with previous observations that hypovolemic or hypotensive AVP secretion is blunted through the action of GABA or a GABA-uptake inhibitor on the periventricular tissue [23, 24] . The muscimol treatment neither decreased plasma ANG II, sodium or osmolality nor increased arterial pressure under hemorrhagic states, suggesting that the diminution of the of which presence has been demonstrated are drawn, using the bold lines with the arrow heads. Neurons in the AV3V (lower part of the lamina terminalis structures encompassed with the dotted line) and subfornical organ (SFO) that trigger AVP secretion in response to a hypovolemic stimulus, as well as to a hypertonic stimulus, send information to AVP cells in the paraventricular nucleus (PVN) and supraoptic nucleus (SON) through pathways with or without synapses at the median preoptic nucleus (MnPO). Noradrenergic neurons (NA n.) project from the ventrolateral medulla (VLM) to the MnPO or from the locus ceruleus (LC) to the organum vasculosum of the lamina terminalis (OVLT). Those NA ns. and other neurons arising from the brainstem areas may be activated under the hypovolemic condition [10, 11, 48] via the carotid sinus nerve (CSN) and aortic depressor nerve (ADN) that transmit peripherally-evoked cardiovascular changes [45] . A part of A1 neurons may project to the AVP cells directly without going through the AV3V [5] . The NAergic signals potentiated by the hypovolemia may act to inhibit GABAergic activity in the AV3V and SFO [22, 51] . GABAergic neurons, as well as glutamatergic neurons, are shown to project from the SFO or OVLT to the MnPO [20] . NTS: nucleus of the solitary tractus; PBN: parabrachial nucleus. Bottom: Interplays between GABAergic and glutamatergic neurons for facilitating AVP secretion that may occur when hypovolemic signals (Hvs) arrive at the AV3V from the brainstem areas in the upper figure are presumed based on our current and previous studies [15] [16] [17] . The star-shaped objects at the right side represent the AVP cells. As stated above, bleeding-evoked Hvs conveyed from the brainstem areas could inactivate asterisked GABAergic neurons [51] to cause resultant potentiation in glutamatergic (Glu) influence on excitatory pathways (Ex) in the models [A] and [B] or on GABAergic neurons innervating inhibitory pathway (In) to the AVP cells in the model [C] . Infusion of the GABAergic antagonist bicuculline may also block function of the asterisked neurons to exert similar potency. Asterisked GABAergic neurons and Glu neurons below them may extend axons from the inside and outside of AV3V [20] .
be lower than expected from the results in Figs. 2 and 4 . Seasonal changes in excitability of autonomic nerves or fluid-retention mechanisms, as well as the individual difference, could be presumed as possible factors that may affect bleeding-evoked AVP secretion in vehicleinfused groups. In this study, therefore, each series of experiments was performed during the same periods by using the same batches of rats.
In conclusion, this study showed that muscimolevoked activation of GABA A receptors in the AV3V was potent to prevent AVP secretion in response to bleeding, the stimulus that was applied alone or together with the i.v. load of hypertonic saline. Taken the results together with the similar AVP-inhibitory potency of the muscimol treatment detected in rats with the osmotic stimulus alone [17] , it seems that inactivation of GABA A receptors in the AV3V may be involved not only in hyperosmotic, but also in hypovolemic AVP secretion. Our findings support the view that hypovolemic inputs may act in the AV3V to modulate the excitability of hypothalamic AVP cells to osmotic stimuli [1, 18] . However, although activation of AV3V GABA B receptors may serve to prevent AVP secretion under hyperosmotic conditions [17] , the manipulation was unable to produce a similar AVPinhibitory action under hypovolemic conditions. Thus, the AV3V mechanisms engaged in AVP regulation are activated by different stimuli and seem to involve different roles of GABA B receptors.
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In contrast to our findings, electrical destruction of the AV3V did not affect hemorrhagic AVP release [27, 28] , raising a suspicion on our view mentioned above. However, the experiments in these studies were performed after a recovery period of 2-3 weeks, during which certain alterations may have developed in the regulatory mechanism for AVP secretion, owing to the appearance of a compensatory mechanism [49] or disturbances evoked in various aspects such as electrolytic levels, hormone release, renal function and water intake [4, 33] . Therefore, such reports cannot always exclude our notion.
Since circulating ANG II may contribute to hypovolemic AVP secretion by acting on the AV3V [7, 50] , it can be presumed that the muscimol infusion attenuated hemorrhagic AVP release by inhibiting the ANG II function. However, this possibility may be unlikely because the AVP response to ICV ANG II was not changed by concomitant application of GABA [46] .
When GABA B receptors in the AV3V or its vicinity were stimulated with the agonist baclofen, arterial pressure and heart rate were enhanced, regardless of the absence or presence of the bleeding manipulation. Thus, the ability to cause hypotension, an AVPreleasing stimulus, was hampered by AV3V infusion with baclofen. Nevertheless, the increases in plasma AVP and glucose caused by the hemorrhages tended to be intensified by the baclofen treatment. Takenaka et al. [26] also reported pressor and tachycardiac actions of baclofen applied to the anterior hypothalamus. Such effects of baclofen may suggest that it weakens the inhibitory potency of GABAergic neurons themselves, or other inhibitory neurons. On the other hand, the aspect of whether baclofen infusion strengthens the hemorrhagic AVP response needs to be ascertained in further investigations, because the hemorrhagic AVP responses in the vehicle group (Fig. 6 ) may appear to
